Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study.
Saved in:
| Title: | Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study. |
|---|---|
| Authors: | Kalsnes J; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Isaksen MX; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Julbø F; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Pradhan M; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Kleppe A; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway.; Department of Informatics, University of Oslo, Norway.; Centre for Research-based Innovation Visual Intelligence, UiT The Arctic University of Norway, Tromsø, Norway., De Raedt S; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Skrede OJ; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Torheim T; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Nesheim JA; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Mohn HM; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Askautrud HA; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Cyll K; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Rewcastle E; Department of Pathology, Stavanger University Hospital, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Norway., Lillesand M; Department of Pathology, Stavanger University Hospital, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Norway., Kvikstad V; Department of Pathology, Stavanger University Hospital, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Norway., Janssen E; Department of Pathology, Stavanger University Hospital, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Norway., Jones R; Department of Hepatobiliary Surgery, Liverpool University Hospitals NHS Foundation Trust, UK.; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK., Brustugun OT; Section of Oncology, Vestre Viken Hospital Trust, Drammen, Norway.; Institute of Clinical Medicine, University of Oslo, Norway., Brennhovd B; Department of Urology, Oslo University Hospital, Norway., Haug ES; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway.; Department of Urology, Vestfold Hospital Trust, Tønsberg, Norway., Busund LR; Department of Medical Biology, UiT, The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway., Richardsen E; Department of Medical Biology, UiT, The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway., Andersen S; Department of Oncology, University Hospital of North Norway, Tromso, Norway.; Institute of Clinical Medicine, UiT, The Arctic University of Norway, Tromso, Norway., Dønnem T; Department of Oncology, University Hospital of North Norway, Tromso, Norway.; Institute of Clinical Medicine, UiT, The Arctic University of Norway, Tromso, Norway., Lindemann K; Institute of Clinical Medicine, University of Oslo, Norway.; Section for Gynecological Oncology, Department of Surgical Oncology, Oslo University Hospital, Norway., Kristensen G; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway.; Section for Gynecological Oncology, Department of Surgical Oncology, Oslo University Hospital, Norway., Shepherd NA; Gloucestershire Cellular Pathology Laboratory, Cheltenham General Hospital, UK., Novelli M; Research Department of Pathology, University College London Medical School, UK., Liestøl K; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway.; Department of Informatics, University of Oslo, Norway., Kerr D; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, UK., Danielsen HE; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway., Hveem TS; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway. |
| Source: | FEBS open bio [FEBS Open Bio] 2026 Jul; Vol. 16 (7), pp. 1259-1270. Date of Electronic Publication: 2026 Feb 12. |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101580716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-5463 (Electronic) Linking ISSN: 22115463 NLM ISO Abbreviation: FEBS Open Bio Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2211-5463 |
|---|---|
| DOI: | 10.1002/2211-5463.70210 |
